Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 425

1.

Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders.

Issakidis C, Sanderson K, Corry J, Andrews G, Lapsley H.

Psychol Med. 2004 Jan;34(1):19-35.

PMID:
14971624
2.

Evidence-based care for alcohol use disorders is affordable.

Corry J, Sanderson K, Issakidis C, Andrews G, Lapsley H.

J Stud Alcohol. 2004 Jul;65(4):521-9.

PMID:
15376827
3.

Reducing the burden of affective disorders: is evidence-based health care affordable?

Sanderson K, Andrews G, Corry J, Lapsley H.

J Affect Disord. 2003 Nov;77(2):109-25.

PMID:
14607388
4.

Evidence-based medicine is affordable: the cost-effectiveness of current compared with optimal treatment in rheumatoid and osteoarthritis.

Andrews G, Simonella L, Lapsley H, Sanderson K, March L.

J Rheumatol. 2006 Apr;33(4):671-80. Epub 2006 Mar 15.

PMID:
16541479
5.

Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.

Bereza BG, Machado M, Einarson TR.

Clin Ther. 2009 Jun;31(6):1279-308. doi: 10.1016/j.clinthera.2009.06.004. Review.

PMID:
19695395
6.

Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders.

Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H.

Br J Psychiatry. 2004 Jun;184:526-33.

7.

Cost-effectiveness of current and optimal treatment for adult asthma.

Simonella L, Marks G, Sanderson K, Andrews G.

Intern Med J. 2006 Apr;36(4):244-50.

PMID:
16640742
8.

Cost-effectiveness of current and optimal treatment for schizophrenia.

Andrews G, Sanderson K, Corry J, Issakidis C, Lapsley H.

Br J Psychiatry. 2003 Nov;183:427-35; discussion 436.

9.

Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.

Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, Andrews G, Vos T.

Aust N Z J Psychiatry. 2004 Aug;38(8):602-12.

PMID:
15298582
10.

Using epidemiological data to model efficiency in reducing the burden of depression*

Andrews G, Sanderson K, Corry J, Lapsley HM.

J Ment Health Policy Econ. 2000 Dec 1;3(4):175-186.

PMID:
11967454
11.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

12.

Assessing cost-effectiveness in mental health: helping policy-makers prioritize and plan health services.

Vos T, Haby MM, Magnus A, Mihalopoulos C, Andrews G, Carter R.

Aust N Z J Psychiatry. 2005 Aug;39(8):701-12.

PMID:
16050924
13.

The burden of major depression avoidable by longer-term treatment strategies.

Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G.

Arch Gen Psychiatry. 2004 Nov;61(11):1097-103.

PMID:
15520357
14.

Cost-outcome of anxiety treatment intervention in primary care in Hungary.

Zámbori J, Szádóczky E, Rózsa S, Füredi J.

J Ment Health Policy Econ. 2002 Sep;5(3):115-20.

PMID:
12728198
15.

Assessing Cost-Effectiveness--Mental Health: introduction to the study and methods.

Haby MM, Carter R, Mihalopoulos C, Magnus A, Sanderson K, Andrews G, Vos T.

Aust N Z J Psychiatry. 2004 Aug;38(8):569-78.

PMID:
15298579
16.

Computerised cognitive behaviour therapy for depression and anxiety update: a systematic review and economic evaluation.

Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G, Sutcliffe P.

Health Technol Assess. 2006 Sep;10(33):iii, xi-xiv, 1-168. Review.

17.

Cost-effectiveness of cognitive-behavioural therapy and drug interventions for major depression.

Vos T, Corry J, Haby MM, Carter R, Andrews G.

Aust N Z J Psychiatry. 2005 Aug;39(8):683-92.

PMID:
16050922
18.

Cost of depression in Europe.

Sobocki P, Jönsson B, Angst J, Rehnberg C.

J Ment Health Policy Econ. 2006 Jun;9(2):87-98.

PMID:
17007486
19.

Economic evaluation of treatments for children with severe behavioural problems.

Muntz R, Hutchings J, Edwards RT, Hounsome B, O'Céilleachair A.

J Ment Health Policy Econ. 2004 Dec;7(4):177-89.

PMID:
15701933
20.

Costs of nine common mental disorders: implications for curative and preventive psychiatry.

Smit F, Cuijpers P, Oostenbrink J, Batelaan N, de Graaf R, Beekman A.

J Ment Health Policy Econ. 2006 Dec;9(4):193-200.

PMID:
17200596
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk